NASDAQ:LTRN | Profit Breakdown | Lantern Pharma Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$3.51M-$7.07M
2026-03-31-$3.41M-$3.33M
2025-12-31-$4.2M-$4.07M
2025-09-30-$4.35M-$4.18M
2025-06-30-$4.65M-$4.33M
2025-03-31-$4.77M-$4.54M
2024-12-31-$5.9M-$5.88M
2024-09-30-$5.18M-$4.51M
2024-06-30-$5.41M-$4.96M
2024-03-31-$5.73M-$5.44M
2023-12-31-$4.88M-$4.19M
2023-09-30-$3.52M-$3.16M
2023-06-30-$5.19M-$4.75M
2023-03-31-$4.29M-$3.87M
2022-12-31-$3.83M-$3.38M
2022-09-30-$2.15M-$2.26M
2022-06-30-$4.39M-$4.49M
2022-03-31-$4.07M-$4.12M
2021-12-31-$3.51M-$3.54M
2021-09-30-$4.15M-$4.05M
2021-06-30-$2.48M-$2.32M
2021-03-31-$2.45M
2020-12-31-$2.9M
2020-09-30-$1.7M-$1.7M
2020-06-30-$833,422.00-$833,422.00
2020-03-31-$477,276.00
2019-12-31-$675,167.00
2019-09-30-$669,652.00
2019-06-30-$629,393.00
2019-03-31-$453,973.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$17.98M-$17.12M
2024-12-31-$22.22M-$20.78M
2023-12-31-$17.88M-$15.96M
2022-12-31-$14.43M-$14.26M
2021-12-31-$12.59M-$12.36M
2020-12-31-$5.91M
2019-12-31-$2.43M